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In this issue, Taylor and colleagues report their experi- 
ence with nosocomial gram-negative bacteremia at the 
University of Alberta Hospital, a Canadian tertiary acute 
care facility.’ The incidence of gram-negative bacteremia 
remained remarkably constant over 10 years even though 
the overall incidence of bacteremia rose, primarily 
because of gram-positive microorganisms. The l-week 
mortality rate associated with gram-negative bacteremia 
declined for reasons that were unclear. This report by 
Taylor et al adds to an enormous, growing, international 
database on the significance of positive blood cultures, 
dating back to the pre-antibiotic em2 But, aside from the 
archival value of monitoring institutional experience, of 
what use is such surveillance to infection control and 
patient care? What types of surveillance activities justify 
their cost? 
Three key terms need to be examined. First, “bac- 
teremia” -the traditional focus of such surveillance- 
denotes the presence of bacteria in blood cultures with 
or without symptoms of disease. Until the late 1970s 
blood culture surveillance was essentially synonymous 
with tracking bacteremias, because other types of organ- 
isms were infrequently isolated from blood.3 During the 
1980s the rising incidence of fungemias made it clear 
that such surveillance should incorporate, at the very 
least, bacteremias and fungemias (Figure 1). Mycobacte- 
ria, viruses, and parasites can also be detected in blood. 
There is no generally accepted inclusive term for the 
presence of microorganisms of any kind in blood. (In 
preparing a review article,* the author once proposed 
“microbemia, )) which was roundly rejected by the review- 
ers, probably for the best!). Another caveat is that the 
focus for clinical intervention trials has shifted from “sep- 
ticemia” (that is, sepsis with positive blood cultures) to 
“sepsis” because many patients with life-threatening infec- 
tion do not have positive blood cultures.5 The correla- 
tion between sepsis and positive blood cultures is now 
being evaluated in various countries.‘j Monitoring blood 
cultures provides an easily obtainable, but incomplete 
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Figure 1. Rates of blood culture utilization, bacteremia, and fungemia 
at Richland Memorial Hospital, a 649-bed regional community teach- 
ing facility in Columbia, South Carolina, 1977 through 1995. 
overview of serious infections. Developments during the 
next century, for example, rapid, broad-spectrum tests 
for microbial DNA or RNA based on the polymerase chain 
reaction, could conceivably render obsolete the time- 
honored focus on blood cultures. 
Second, although “nosocomial” bacteremia obviously 
refers to acquisition in the hospital rather than in the 
community, this distinction can be surprisingly difficult. 
In 1970, nosocomial bacteremia was defined at the First 
International Conference on Nosocomial Infections as 
“culture-documented bacteremia in a hospitalized patient 
admitted with no evidence of bacteremia.“’ In 1975, 
McGowan and colleagues proposed that nosocomial bac- 
teremia can be defined, for survey purposes, as one on 
which the first positive blood culture is obtained on or 
after the third hospital day.* In 1983, the Centers for Dis- 
ease Control (CDC) definitions were refmed so that “for 
an infection to be defined as nosocomial, there must be 
no evidence that the infection was present or incubating 
at the time of hospital admission!‘9 Still more recently, 
the adjective “nosohusial” has been introduced for infec- 
tions related to home health care.‘O The author’s personal 
preference is to use McGowan’s definition for epidemi- 
ologic surveillance purposes, recognizing that such work- 
ing definitions do not always correlate with what actually 
happened. The other defmitions require closer scrutiny 
of individual patient records, which may or not provide 
important information that justifies labor and cost. 
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Finally, the term “mortality rate” must also be quali- 
fied. Taylor and colleagues followed each patient “ 1 week 
from first positive blood culture to determine short-term 
outcome.” This approach is utilitarian but, as the authors 
surely recognized, does not necessarily correlate with 
clinical reality. In analysis of 1186 episodes of gram-neg- 
ative bacteremia, the authors defined deaths due to infec- 
tion as being those within 7 days of the last positive blood 
cultures, with no obvious alternative explanation for 
death.” Weinstein and his colleagues, in their study of 
500 consecutive cases of bacteremia and fungemia, con- 
cluded that deaths were attributable to infection only 
after perusal of the hospital record by two physician- 
investigators, working independently.12s13 Subsequent 
investigators have distinguished between “crude mortal- 
ity” (all deaths during hospitalization) and “attributable 
mortality” (deaths due to the infection). Wenzel defined 
attributable mortality as the difference between the over- 
all case fatality rate for infected patients and the overall 
case fatality rate for well-matched control patients.l* Iden- 
tifying well-matched controls is labor-intensive, at least at 
most institutions. Nevertheless, the difference between 
crude mortality and attributable mortality assumes soci- 
etal importance especially with regard to difficult-to-treat 
pathogens such as vancomycin-resistant enterococci.15 
With these caveats in mind, there are five areas in 
which blood culture surveillance gives potentially useful 
information: 
1. Ongoing surveillance of nosocomial infection. 
The endemic or background incidence of positive blood 
cultures at any institution correlates in a general way with 
the severity of illness (acuity) among the patient popu- 
1ation.l’ Also, positive blood cultures are invaluable for 
many diagnoses. One must remember that many micro- 
bial species, and especially gram-positive bacteria (noto- 
riously Staphylococcus epidermidis, but also other 
species), often are contaminants rather than true 
pathogens. 12,13 Of interest, the only blood culture sur- 
veillance currently used in the CDC’s National Nosoco- 
mial Infections Surveillance (NNIS) system concerns the 
number of primary infections per 1000 central venous 
catheter (“line”) days.” Unfortunately, determining that 
infection is primary, as opposed to secondary from an 
identified infection, can be arbitrary, and determining the 
number of line-days can be time-consuming. Gold stan- 
dards for line-related infections do not exist, and inter- 
pretation of such data is difficult unless all clinicians 
follow a standardized protocol.ls 
2. Outbreak investigation. Ongoing blood culture 
surveillance facilitates early identification of some types 
of outbreaks. These usually (79% of outbreaks in one 
recent review) involve gram-negative rods.‘9 Intensive 
care units are the usual setting for such outbreaks, which 
are to some extent even predictable. For example, based 
on reports in the literature a group may discuss ways to 
manage gentamicin-resistant Klebsiella pneumoniae bac- 
teremia in the neonatal intensive care unit well before 
being faced with such an outbreak.2o Nationwide (or even 
international) outbreaks can result from contamination of 
intravenous fluids or blood products, and potentially from 
medications.21 Outbreaks due to fungal pathogens (most 
commonly due to Malassezia furfur from lipid-contain- 
ing preparations, but also others) are also well recog- 
nized. 
3. Microbiology laboratory quality control. None 
of the numerous alternative methods for collecting, pro- 
cessing, and reporting of blood cultures meets all desider- 
ata.22-z4 Pseudoepidemics (that is, the epidemic occurrence 
of false-positive blood cultures) can result from problems 
with skin contamination, phlebotomy, media preparation, 
or laboratory processing. 25 Pseudobacteremia due to 
coagulase-negative staphylococci is hyperendemic at 
many institutions. At Richland Memorial Hospital, a deci- 
sion to discontinue routine use of a quantitative blood cul- 
ture system (the lysis-centrifugation system [ISOLATOR], 
Wampole Laboratories, Cranbury, New Jersey) decreased 
the ability to recognize such cases of pseudobacteremia, 
thereby explaining the increased number of gram-positive 
bacteremias noted during 1995 (see Figure 1). Monitor- 
ing blood cultures also provides a way to give feedback 
to the medical staff concerning the performance of blood 
cultures and the significance of the results.26b27 It is use- 
ful to monitor the ratio of blood cultures obtained to pos- 
itive results (historically, about 10: 1 at Richland Memorial 
Hospital). 
4. Antibiotic review. Drug-resistant microorganisms 
are rapidly becoming a major problem, to the extent that 
many authorities predict a “post-antibiotic era” in which 
life-threatening infections may be essentially untreatable.z8 
Judicious prescribing of antimicrobial agents is widely 
taught but difficult to ensure. Blood culture surveillance 
furnishes data that bear on such clinical decisions as 
whether to prescribe vancomycin empirically for sus- 
pected Staphylococcus aureus or enterococcal infection. 
Concurrent review of antimicrobial therapy for each 
patient with a positive blood culture helps ensure that 
therapy is both appropriate and judicious. The method 
consists of carrying out a prompt review of the clinical 
scenario and drug treatment for each patient with a 
newly identified positive culture, offering advice to the 
physician(s) caring for the patient when indicated.29 An 
extensive and easily obtainable literature exists for nearly 
all of the commonly encountered bloodstream pathogens, 
and clinicians usually find such “automatic consultations” 
to be useful. However, this activity is labor-intensive and 
may require additional personnel. 
5. Evaluation of overall patterns of clinical care. In 
the author’s experience, the overall hospital mortality 
(crude case fatality rate) was 30% for patients with pos- 
itive blood cultures, compared with 2.5% for the overall 
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Table 1. Proposed Levels of Intensity of Routine Blood Culture Surveillance 
Level Procedure Potential Benefits 
1, least intense Monitor number of blood cultures performed 
and number of positive cultures 
Feedback to medical staff on blood culture utilization 
Record number of cultures revealing gram-positive 
bacteria, number of gram-negative bacteria, number 
of fungi, and number revealing miscellaneous 
microorganisms, such as mycobacteria 
Feedback to medical staff on empirical use of selected 
antibiotics for suspected sepsis 
Periodically review sensitivity profiles of key 
microorganisms (for example, Streptococcus pneumoniae, 
S. aureus, Enterococcus faecium, and Pseudomonas 
aeruginosa) 
Early recognition of epidemics and pseudoepidemics 
2, intermediate intensity Tabulate species of all organisms for institution and for Feedback to all health care workers on efficacy of all 
each clinical unit on a regular (e.g., monthly) basis infection control practice 
Tabulate sensitivity profiles for all blood culture isolates, 
by species, on a regular (e.g., every 6 months) basis 
Feedback to all health care workers on antibiotic use 
Tabulate incidence of nosocomial as opposed to community- Feedback to workers in intensive care units regarding 
3, most intense 
acquired onset for each case as determined by one or 
another criterion, with specific emphasis on vascular access 
(“line”)-associated cases 
care of central lines 
Periodically review all cases of positive blood cultures due Feedback to all health care workers about problem 
to one or another pathogen pathogens 
Conduct in-depth, concurrent medical record (chart) review 
of each patient found to have a new positive blood culture, 
making recommendations to the staff concerning 
management 
Complete an epidemiologically oriented fact sheet for 
each positive blood culture, recording such information as 
the probable source of infection, antimicrobial therapy, and 
outcome, as part of an ongoing study of infectious diseases 
at one’s facility 
Assurance that patients with life-threatening infections 
receive appropriate treatment 
In-depth feedback to health care workers about 
selected infectious disease problems 
Investigational 
(useful at selected 
institutions) 
Phenotyping and/or genotyping of blood culture isolates Early recognition of small clusters or outbreaks of 
nosocomial infection 
Analysis of the cost of medical care of patients with positive 
blood cultures vs. cost of medical care for matched 
control patients 
Cold storage of blood culture isolates for future studies 
Economic analysis of the efficacy of infection control 
measures 
Evaluation of long-term trends in hospital-associated 
microbial ecology 
hospital population. l6 Positive blood cultures thus iden- 
tify a subset of patients at grave risk of complications. It 
is well recognized that this picture may be incomplete in 
certain groups of patients, such as the elderly, in whom 
manifestations of sepsis may be subtle.30,31 Positive blood 
cultures provide data that are relevant in both human 
and economic terms, and should therefore be of interest 
to those who are concerned with the larger socioeco- 
nomic dimensions of medicine, including hospital admin- 
istrators and government policy-makers3* 
In 1969, Martin proposed that a national bacteremia 
databank be established in the United States.33 In 1987, 
Wenzel proposed that attributable mortality due to bac- 
teremia should be introduced as a new vital statistic.‘* 
No widespread movement to implement these sugges- 
tions has been forthcoming. It seems reasonable to sug- 
gest that each institution should review its level of 
commitment to obtaining data concerning positive blood 
cultures (Table 1). 
The data reported by Taylor and colleagues in this 
issue remind us of the value of monitoring positive blood 
cultures. Each institution will have its unique experience 
and will find such monitoring to be worthwhile. Blood 
culture surveillance need not be unusually elaborate or 
Blood Culture Surveillance / Bryan 185 
time-consuming, and it is gratifying to observe that com- 
prehensive studies based on this activity continue to be 
reported from various countries around the world.34x3j 
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